DVS Q4 2025 Earnings Silver Developer Reports WiderThanExpected Loss Amid PreRevenue Phase ACRS Q1 2026 Earnings Narrower Net Loss Beats Expectations as Cost Management Continues ZTO Q1 2026 Earnings Robust EPS Reported Amidst Revenue Disclosure Gap Bioventus BVS Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Opacity EFXT Q1 2026 Earnings Earnings Surge Past Estimates by 65 JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline